Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-03-17FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for galantamine from Aurobindo Pharma Limited, allowing the marketed generic product to proceed.
-
FDA approval · 2022-03-15FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for galantamine hydrobromide from Sun Pharmaceutical Industries, Inc., authorizing a generic version…
-
EMA approval · 2022-01-05EMA Authorised: Ebixa (memantine hydrochloride) — H. Lundbeck A/S
European Medicines Agency authorised Ebixa (memantine hydrochloride) for Alzheimer disease.
-
EMA approval · 2021-12-08EMA Authorised: Marixino (previously Maruxa) (memantine hydrochloride) — KRKA, d.d.
Authorised medicinal product Marixino (memantine hydrochloride) for Alzheimer disease in the EU.
-
FDA approval · 2021-08-09FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic memantine hydrochloride product from Aurobindo Pharma Limited under an Original Application (ANDA214651).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-04-02FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the original application for memantine hydrochloride (generic) from Slate Run Pharmaceuticals, LLC via an ANDA.
-
FDA approval · 2021-01-25FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s supplemental application for memantine hydrochloride. This action confirms continued approval of t…
-
FDA approval · 2020-12-11FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (POLYGEN PHARMACEUTICALS INC.)
The FDA approved an original ANDA for memantine hydrochloride by PolyGen Pharmaceuticals, enabling a generic version of memantine for Alzhei…
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited, updating an existing approved produ…
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride by Macleods Pharmaceuticals Limited, indicating approval of a change…
-
FDA approval · 2020-11-13FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for donepezil hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2020-09-21FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for a generic donepezil hydrochloride product manufactured by Solco Healthcare US, LLC.
-
FDA approval · 2020-08-31FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Seton Pharmaceuticals)
FDA approved Seton Pharmaceuticals' Original Application for memantine hydrochloride oral, the generic version of memantine.
-
FDA approval · 2020-08-11FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for donepezil hydrochloride by ScieGen Pharmaceuticals, Inc. The action relates to regulatory ap…
-
FDA approval · 2020-06-02FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for a generic memantine hydrochloride product.
-
FDA approval · 2020-05-28FDA Approved: TAUVID — Original Application (Eli Lilly and Company)
FDA approved Tauvid (flortaucipir F-18) for PET imaging to estimate tau neurofibrillary tangles in the brains of adult patients with known o…
-
FDA approval · 2020-04-03FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Carlsbad Technology, Inc.)
The FDA approved an original application for memantine hydrochloride by Carlsbad Technology, Inc. The drug is a generic version of memantine…
-
FDA approval · 2020-03-18FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal Pharmaceuticals' supplemental ANDA for memantine hydrochloride, a generic memantine product for the treatment of symptom…
-
FDA approval · 2020-03-15FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for memantine hydrochloride from Rising Pharma Holdings, Inc.
-
FDA approval · 2020-03-15FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for memantine hydrochloride filed by Zydus Lifesciences Limited. This action relates to the appr…
-
FDA approval · 2020-01-10FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approved a supplemental application for Vizamyl (flutemetamol F-18) from GE Healthcare, expanding its regulatory authorization to includ…
-
FDA approval · 2020-01-10FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (florbetaben F-18) from Lantheus Biosciences Ltd., granting continued approval for its …
-
FDA approval · 2019-12-30FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved Hisun Pharmaceuticals USA, Inc.'s supplemental application for donepezil hydrochloride, a generic medication for the treatment …
-
FDA approval · 2019-12-20FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for AMYVID (Florbetapir F 18) from Eli Lilly and Company.
-
FDA approval · 2019-12-04FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for memantine hydrochloride, a generic form of the Alzheimer's disease therapy.